Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

计划入组 22 人 · 首次发布于 2007 年 5 月 22 日

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

计划入组 44 人 · 首次发布于 2011 年 7 月 13 日

Cytokine Induced Killer (CIK) Cells In Leukemia Patients

计划入组 74 人 · 首次发布于 2010 年 8 月 23 日

dendritic activated cytokine-induced killer cell

DC-CIK cells (Shenzhen Hornetcorn)

Autologous Tumor Tissue Antigen Sensitized DC-CIK Cells

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

KLSMC Stem Cells, Inc.

Dual PD-1/CTLA-4 Immunotherapy Shows Promise in Ovarian Cancer Treatment

Cell Therapy Advances Show Promise for Hepatocellular Carcinoma Treatment

Neoadjuvant Immunotherapy Shows Promise as Bridge to Liver Transplant in HCC, but Rejection Risk Demands Caution